Nutrigenomics and Cancer Prevention

Current Nutrition Reports

Volumn 1, Issue 1, 2012, Pages 37-43

  Nicastro, Holly L ^a   Trujillo, Elaine B ^a   Milner, John A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Bioactive food components; Cancer; Cancer prevention; Diet; Epigenetics; Metabolomics; Microbiomics; Nutrigenomics; Proteomics; Transcriptomics

Indexed keywords

ALPHA TOCOPHEROL; ANACARDIC ACID; BETA CAROTENE; CAFFEIC ACID; CALCITRIOL; COUMARIC ACID; CURCUMIN; CYTOCHROME P450; EPIGALLOCATECHIN GALLATE; GENISTEIN; GLUCOSE TRANSPORTER 2; HESPERIDIN; HISTONE DEACETYLASE; ISOTHIOCYANIC ACID DERIVATIVE; LYCOPENE; MESSENGER RNA; OMEGA 3 FATTY ACID; PHLORETIN; QUERCETIN; RESVERATROL; SULFORAPHANE; THIOL DERIVATIVE; TRANSCRIPTION FACTOR CDX2; VEGETABLE PROTEIN; VITAMIN D RECEPTOR; XRCC1 PROTEIN;

CALCIUM ABSORPTION; CALCIUM INTAKE; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; COLON CANCER; COLORECTAL CANCER; DIET THERAPY; ENZYME POLYMORPHISM; EPIGENETICS; FAT INTAKE; GENE AMPLIFICATION; GENE EXPRESSION; GENE SILENCING; GENETIC VARIABILITY; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HAPLOTYPE; HUMAN; LUNG CANCER; METABOLOMICS; MICROFLORA; NEOPLASM; NONHUMAN; NUTRIGENOMICS; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEOMICS; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SOYBEAN; TRANSCRIPTOMICS;

EID: 84887827414     PISSN: None     EISSN: 21613311     Source Type: Journal    
DOI: 10.1007/s13668-011-0007-6     Document Type: Review

References (61)

1. •• Feero WG, Guttmacher AE, Collins FS: Genomic medicine-an updated primer. N Engl J Med 2010, 362: 2001-2011. This review thoroughly discusses recent advances in genomics.
2. Burke W, Khoury MJ, Stewart A, Zimmern RL. The path from genome-based research to population health: development of an international public health genomics network. Genet Med. 2006; 8: 451-8.
3. Wu AH, Yu MC, Tseng CC, Pike MC. Epidemiology of soy exposures and breast cancer risk. Br J Cancer. 2008; 98: 9-14.
4. Trock BJ, Hilakivi-Clarke L, Clarke R. Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst. 2006; 98: 459-71.
5. • Dong JY, Qin LQ: Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies. Breast Cancer Res Treat 2011, 125: 315-323. This meta-analysis highlights the role that timing of exposure can play in studies on food components and cancer risk.
6. Wu AH, Wan P, Hankin J, et al. Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis. 2002; 23: 1491-6.
7. Shu XO, Jin F, Dai Q, et al. Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev. 2001; 10: 483-8.
8. Hilakivi-Clarke L, Andrade JE, Helferich W. Is soy consumption good or bad for the breast? J Nutr. 2010; 140: 2326S-34S.
9. Lampe JW, Potter JD: Genetic variation, diet, and disease susceptibility. In Gene-Environment Interactions: Fundamentals of Ecogenetics. Edited by. Hoboken: John Wiley & Sons, Inc.; 2006.
10. Breen FM, Plomin R, Wardle J. Heritability of food preferences in young children. Physiol Behav. 2006; 88: 443-7.
11. Bady I, Marty N, Dallaporta M, et al. Evidence from glut2-null mice that glucose is a critical physiological regulator of feeding. Diabetes. 2006; 55: 988-95.
12. Eny KM, Wolever TM, Fontaine-Bisson B, El-Sohemy A. Genetic variant in the glucose transporter type 2 is associated with higher intakes of sugars in two distinct populations. Physiol Genomics. 2008; 33: 355-60.
13. Wong HL, Seow A, Arakawa K, et al. Vitamin D receptor start codon polymorphism and colorectal cancer risk: effect modification by dietary calcium and fat in Singapore Chinese. Carcinogenesis. 2003; 24: 1091-5.
14. Abrams SA, Griffin IJ, Hawthorne KM, et al. Vitamin D receptor Fok1 polymorphisms affect calcium absorption, kinetics, and bone mineralization rates during puberty. J Bone Miner Res. 2005; 20: 945-53.
15. Food N, Activity P. and the Prevention of Cancer: A Global Perspective. Washington, DC: AICR; 2007.
16. Slattery ML, Herrick J, Wolff RK, et al. CDX2 VDR polymorphism and colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2007; 16: 2752-5.
17. Goodman M, Bostick RM, Ward KC, et al. Lycopene intake and prostate cancer risk: effect modification by plasma antioxidants and the XRCC1 genotype. Nutr Cancer. 2006; 55: 13-20.
18. Kury S, Buecher B, Robiou-du-Pont S, et al. Combinations of cytochrome P450 gene polymorphisms enhancing the risk for sporadic colorectal cancer related to red meat consumption. Cancer Epidemiol Biomarkers Prev. 2007; 16: 1460-7.
19. Ingelman-Sundberg M, Sim SC, Gomez A, Rodriguez-Antona C. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacol Ther. 2007; 116: 496-526.
20. Perry GH, Dominy NJ, Claw KG, et al. Diet and the evolution of human amylase gene copy number variation. Nat Genet. 2007; 39: 1256-60.
21. Slamon DJ, Clark GM, Wong SG, et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987; 235: 177-82.
22. Link A, Balaguer F, Goel A. Cancer chemoprevention by dietary polyphenols: promising role for epigenetics. Biochem Pharmacol. 2010; 80: 1771-92.
23. Heijmans BT, Tobi EW, Stein AD, et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci U S A. 2008; 105: 17046-9.
24. Stidley CA, Picchi MA, Leng S, et al. Multivitamins, folate, and green vegetables protect against gene promoter methylation in the aerodigestive tract of smokers. Cancer Res. 2010; 70: 568-74.
25. Fang MZ, Wang Y, Ai N, et al. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res. 2003; 63: 7563-70.
26. Fini L, Selgrad M, Fogliano V, et al. Annurca apple polyphenols have potent demethylating activity and can reactivate silenced tumor suppressor genes in colorectal cancer cells. J Nutr. 2007; 137: 2622-8.
27. Glozak MA, Seto E. Histone deacetylases and cancer. Oncogene. 2007; 26: 5420-32.
28. Myzak MC, Dashwood RH. Histone deacetylases as targets for dietary cancer preventive agents: lessons learned with butyrate, diallyl disulfide, and sulforaphane. Curr Drug Targets. 2006; 7: 443-52.
29. Holloway AF, Oakford PC. Targeting epigenetic modifiers in cancer. Curr Med Chem. 2007; 14: 2540-7.
30. Dashwood RH, Ho E. Dietary histone deacetylase inhibitors: from cells to mice to man. Semin Cancer Biol. 2007; 17: 363-9.
31. Petricoin EF, Liotta LA. Clinical applications of proteomics. J Nutr. 2003; 133: 2476S-84S.
32. Liew CC, Ma J, Tang HC, et al. The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J Lab Clin Med. 2006; 147: 126-32.
33. Davidson LA, Nguyen DV, Hokanson RM, et al. Chemopreventive n-3 polyunsaturated fatty acids reprogram genetic signatures during colon cancer initiation and progression in the rat. Cancer Res. 2004; 64: 6797-804.
34. Sunde RA. mRNA transcripts as molecular biomarkers in medicine and nutrition. J Nutr Biochem. 2010; 21: 665-70.
35. Cheung KL, Kong AN. Molecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer chemoprevention. AAPS J. 2010; 12: 87-97.
36. Al Tamimi DM, Shawarby MA, Ahmed A, et al. Protein expression profile and prevalence pattern of the molecular classes of breast cancer-a Saudi population based study. BMC Cancer. 2010; 10: 223.
37. Ornish D, Magbanua MJ, Weidner G, et al. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proc Natl Acad Sci U S A. 2008; 105: 8369-74.
38. van Erk MJ, Blom WA, van Ommen B, Hendriks HF. High-protein and high-carbohydrate breakfasts differentially change the transcriptome of human blood cells. Am J Clin Nutr. 2006; 84: 1233-41.
39. Zhu J, Ding J, Ding F. Tumor stem cell, or its niche, which plays a primary role in tumorigenesis? World J Gastrointest Oncol. 2010; 2: 218-21.
40. Ben-Porath I, Thomson MW, Carey VJ, et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet. 2008; 40: 499-507.
41. Langelier B, Linard A, Bordat C, et al. Long chain-polyunsaturated fatty acids modulate membrane phospholipid composition and protein localization in lipid rafts of neural stem cell cultures. J Cell Biochem. 2010; 110: 1356-64.
42. Trosko JE. Role of diet and nutrition on the alteration of the quality and quantity of stem cells in human aging and the diseases of aging. Curr Pharm Des. 2008; 14: 2707-18.
43. Alexander LS, Mahajan A, Odle J, et al. Dietary phosphate restriction decreases stem cell proliferation and subsequent growth potential in neonatal pigs. J Nutr. 2010; 140: 477-82.
44. Kussmann M, Affolter M. Proteomics at the center of nutrigenomics: comprehensive molecular understanding of dietary health effects. Nutrition. 2009; 25: 1085-93.
45. Rahman MA, Amin AR, Shin DM. Chemopreventive potential of natural compounds in head and neck cancer. Nutr Cancer. 2010; 62: 973-87.
46. Thongboonkerd V. Proteomics. Forum Nutr. 2007; 60: 80-90.
47. Xiao Z, Blonder J, Zhou M, Veenstra TD. Proteomic analysis of extracellular matrix and vesicles. J Proteomics. 2009; 72: 34-45.
48. Mitchell BL, Yasui Y, Lampe JW, et al. Evaluation of matrix-assisted laser desorption/ionization-time of flight mass spectrometry proteomic profiling: identification of alpha 2-HS glycoprotein B-chain as a biomarker of diet. Proteomics. 2005; 5: 2238-46.
49. Yuan Q, Fontenele-Neto JD, Fricker LD. Effect of voluntary exercise on genetically obese Cpefat/fat mice: quantitative proteomics of serum. Obes Res. 2004; 12: 1179-88.
50. Wenzel U, Herzog A, Kuntz S, Daniel H. Protein expression profiling identifies molecular targets of quercetin as a major dietary flavonoid in human colon cancer cells. Proteomics. 2004; 4: 2160-74.
51. Oliver SG. Functional genomics: lessons from yeast. Philos Trans R Soc Lond B Biol Sci. 2002; 357: 17-23.
52. Kim YS, Maruvada P. Frontiers in metabolomics for cancer research: Proceedings of a National Cancer Institute workshop. Metabolomics. 2008; 4: 105-13.
53. Ellis DI, Dunn WB, Griffin JL, et al. Metabolic fingerprinting as a diagnostic tool. Pharmacogenomics. 2007; 8: 1243-66.
54. Gatenby RA, Gillies RJ. Glycolysis in cancer: a potential target for therapy. Int J Biochem Cell Biol. 2007; 39: 1358-66.
55. Kim YS, Milner JA. Bioactive food components and cancer-specific metabonomic profiles. J Biomed Biotechnol. 2011; 2011: 721213.
56. Solanky KS, Bailey NJ, Beckwith-Hall BM, et al. Biofluid 1H NMR-based metabonomic techniques in nutrition research-metabolic effects of dietary isoflavones in humans. J Nutr Biochem. 2005; 16: 236-44.
57. Davis CD, Milner JA. Gastrointestinal microflora, food components and colon cancer prevention. J Nutr Biochem. 2009; 20: 743-52.
58. O'Keefe SJ, Ou J, Aufreiter S, et al. Products of the colonic microbiota mediate the effects of diet on colon cancer risk. J Nutr. 2009; 139: 2044-8.
59. Lampe JW. Emerging research on equol and cancer. J Nutr. 2010; 140: 1369S-72S.
60. Larrosa M, Gonzalez-Sarrias A, Garcia-Conesa MT, et al. Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities. J Agric Food Chem. 2006; 54: 1611-20.
61. Corthesy B, Gaskins HR, Mercenier A. Cross-talk between probiotic bacteria and the host immune system. J Nutr. 2007; 137: 781S-90S.